Join the ERTC

The ERTC (EURORDIS Round Table of Companies), launched in 2004, is a “club” for pharmaceutical companies who share a common interest in rare diseases and orphan drug development. ERTC members provide financial support to EURORDIS and in return their company benefits from the constructive dialogue being developed between industry, patient organisations, as well as national and European authorities.

Now well-established, its members numbered 37 in 2011.

Since its inception, EURORDIS has gained expertise in dealing with the various public and private institutions involved in the rare disease and orphan drug fields. Now we can share this expertise with the pharmaceutical industry, mainly through the ERTC program.

Pharmaceutical companies interested in rare diseases are confronted with very specific hurdles that lie in the path of product development for rare diseases in Europe. These are not the same as in the US where a specific rare disease policy has existed since 1983. The multicultural and heterogeneous legislative environment in the EU adds to the difficulty for orphan drug developers.

EURORDIS is fully aware of the bottlenecks and obstacles in developing products for rare diseases in Europe. In addition to being one of the main promoters of the EU Orphan Drug Regulation, we are a member of the COMP (Committee of Orphan Medicinal Products) and actively involved in the designation procedure of orphan medicinal products at the EMA (European Medicines Agency).

Membership benefits

  • Participation in 2 Round Table of Companies' Workshops per year focusing on issues suggested by the members. These workshops aim to accelerate the development as well as availability of treatments and health services in Europe. They also seek to build relationships with the patient community in a collaborative atmosphere that facilitates discussion (More information about ERTC workshops).
  • Timely reports, surveys and analysis relevant to the field of orphan drugs and rare diseases from different sources (EURORDIS, NORD, EMA, FDA, European Commission, EFPIA/EBE/EuropaBio, academic researchers).
  • Opportunities to interact with other companies in a neutral venue
  • Opportunities for direct exchange of views with leaders of the rare disease community
  • Opportunities to develop partnerships and collaborations with patient groups 
  • Mention of ERTC members on EURORDIS ' website (see Members of the Round Table of Companies), with a logo and a direct link to the websites of the companies
  • Financial support acknowledged in the annual report



Ruby member - 25 000 €

  • Up to 5 participants to workshops
  • Company listed on EURORDIS' website with logo and a link to the company's website
  • Financial support acknowledged in annual report

 

Emerald member - 10 000 €

  • Up to 2 participants to workshops
  • Company listed on EURORDIS' website with logo and a link to the company's website
  • Financial support acknowledged in annual report

 

Sapphire member - 5 000 €

  • 1 participant per workshop
  • Company listed on EURORDIS' website with logo and a link to company website
  • Financial support acknowledged in annual report

 

Round Table Membership



Membership application

Complete and return the membership application (available in pdf and word formats) to the address below.



The EURORDIS Round Table of Companies
EURORDIS
Plateforme Maladies Rares
96, rue Didot
75014 PARIS
FRANCE

Fax: + 33 (0)1 56 53 52 15

Your contact details



Please include a cheque or a copy of the bank transfer.

We look forward to welcoming you to the EURORDIS Round Table of Companies.
If you have any questions about the ERTC, please contact:

Ms. Anne-Mary Bodin
anne-mary.bodin@eurordis.org
Project Assistant


Page created: 19/08/2009
Page last updated: 06/02/2012